| |
| |
|
| Insider
Information: |
Gilead Sciences Inc |
| Relationship: |
10% Owner |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
9 |
|
| Direct
Shares |
104,570,533 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$530,227,253 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
104,570,533 |
|
|
| Total
Value |
$530,227,253 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
4
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
4
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-4.0
|
0.0
|
| Percentage
Gain/Loss : |
 -23.7%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Achillion Pharmaceuticals Inc |
ACHN |
10% Owner |
2006-10-31 |
1,115,839 |
2006-10-31 |
0 |
Premium* |
|
|
Arcus Biosciences Inc |
RCUS |
10% Owner |
2024-01-29 |
30,061,124 |
|
0 |
Premium* |
|
|
Jounce Therapeutics Inc |
JNCE |
10% Owner |
2020-10-16 |
5,539,727 |
|
0 |
Premium* |
|
|
Allovir Inc |
ALVR |
10% Owner |
2023-06-27 |
16,635,286 |
|
0 |
Premium* |
|
|
Assembly Biosciences Inc |
ASMB |
10% Owner |
2023-10-16 |
13,073,668 |
|
0 |
Premium* |
|
|
Hookipa Pharma Inc. |
HOOK |
10% Owner |
2023-12-20 |
18,759,465 |
|
0 |
Premium* |
|
|
Arcellx, Inc. |
ACLX |
10% Owner |
2023-12-28 |
6,720,803 |
|
0 |
Premium* |
|
|
Xilio Therapeutics, Inc. |
XLO |
10% Owner |
2024-04-02 |
7,345,473 |
2024-04-02 |
0 |
Premium* |
|
|
Leap Therapeutics, Inc. |
LPTX |
10% Owner |
2024-04-10 |
5,319,148 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LPTX |
Leap Therapeutics, Inc. |
10% Owner |
– – • |
2024-04-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,319,148 |
|
% |
|
| XLO |
Xilio Therapeutics, Inc. |
10% Owner |
– – • |
2024-04-02 |
4 |
B |
$0.76 |
$368,790 |
D/D |
485,250 |
7,345,473 |
2.45 |
- |
|
| XLO |
Xilio Therapeutics, Inc. |
10% Owner |
– – • |
2024-03-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,860,223 |
|
- |
|
| RCUS |
Arcus Biosciences Inc |
10% Owner |
– – • |
2024-01-29 |
4 |
B |
$21.00 |
$319,999,995 |
D/D |
15,238,095 |
30,061,124 |
2.45 |
% |
|
| ACLX |
Arcellx, Inc. |
10% Owner |
– – • |
2023-12-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,720,803 |
|
- |
|
| HOOK |
Hookipa Pharma Inc. |
10% Owner |
– – • |
2023-12-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
18,759,465 |
|
- |
|
| ASMB |
Assembly Biosciences Inc |
10% Owner |
– – • |
2023-10-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
13,073,668 |
|
% |
|
| RCUS |
Arcus Biosciences Inc |
10% Owner |
– – • |
2023-06-28 |
4 |
B |
$19.26 |
$19,452,600 |
D/D |
1,010,000 |
14,823,029 |
2.45 |
% |
|
| ALVR |
Allovir Inc |
10% Owner |
– – • |
2023-06-27 |
4 |
B |
$3.75 |
$10,990,763 |
D/D |
2,930,870 |
16,635,286 |
2.45 |
% |
|
| ALVR |
Allovir Inc |
10% Owner |
– – • |
2022-07-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
13,704,416 |
|
% |
|
| RCUS |
Arcus Biosciences Inc |
10% Owner |
– – • |
2021-01-31 |
4 |
B |
$39.00 |
$220,350,000 |
D/D |
5,650,000 |
13,913,029 |
2.45 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
10% Owner |
– – • |
2020-10-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,539,727 |
|
% |
|
| RCUS |
Arcus Biosciences Inc |
10% Owner |
– – • |
2020-07-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
8,163,029 |
|
% |
|
| ACHN |
Achillion Pharmaceuticals... |
10% Owner |
– – • |
2006-10-31 |
4 |
A |
$0.00 |
$0 |
D/D |
1,115,839 |
1,115,839 |
0 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
